Medical and Pharmaceutical Breath tests could soon become key diagnosis tool for multiple diseases Researchers are working to bring this technology to market Joseph Morton5 days ago
Medical and Pharmaceutical International lung cancer screening market poised for steady growth: 2025 report It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says Rowan DunneMay 9, 2025
Medical and Pharmaceutical Breath Diagnostics gives the public the chance to join the fight against cancer Regulation crowdfunding allows a startup or private company to reach out directly to the public for support Joseph MortonMay 7, 2025
Medical and Pharmaceutical Breath Diagnostics now offering a compelling investment opportunity The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing Rowan DunneMay 7, 2025
Medical and Pharmaceutical Could robots be the solution to lung cancer imaging woes? The institute is looking to implement a marriage between robotic bronchoscopy and advanced imaging technology Joseph MortonMay 6, 2025
Medical and Pharmaceutical AstraZeneca and AI startup join forces in the fight against lung cancer The integration of AI into routine imaging processes has proven to be a cost-effective triaging tool Joseph MortonMay 1, 2025
Medical and Pharmaceutical Regulus Therapeutics shares jump 135% on news of acquisition by Novartis The buyer is offering a significant premium to acquire Regulus Joseph MortonApril 30, 2025
Medical and Pharmaceutical Japanese startup ‘Craif’ raises US$22M to bring urine cancer biopsy to the U.S. Japan's venture capital firm X&KSK led the Series C round Rowan DunneApril 28, 2025
Medical and Pharmaceutical CG Oncology shares jump on positive clinical trial data for cancer drug The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations Joseph MortonApril 28, 2025
Medical and Pharmaceutical Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment China's National Medical Products Administration approved the initial new drug application in January Rowan DunneApril 25, 2025